Elliott Waives BioMarin Board Deal, Moots Del. Suit
Law 360
APRIL 17, 2024
Elliott Investment Management LP has waived an agreement with BioMarin Pharmaceutical Inc. that gave the activist investor three new seats on the biopharmaceutical company's board, mooting a Delaware Chancery Court lawsuit that a BioMarin shareholder filed earlier this month.
Let's personalize your content